HTG MOLECULAR DIAGNOSTICS, INC Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2015 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Htg Molecular Diagnostics, Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2015 to Q1 2023.
  • Htg Molecular Diagnostics, Inc Share-based Payment Arrangement, Expense for the quarter ending March 31, 2023 was $137K, a 48.8% decline year-over-year.
  • Htg Molecular Diagnostics, Inc Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2023 was $643K, a 47.9% decline year-over-year.
  • Htg Molecular Diagnostics, Inc annual Share-based Payment Arrangement, Expense for 2022 was $774K, a 41.2% decline from 2021.
  • Htg Molecular Diagnostics, Inc annual Share-based Payment Arrangement, Expense for 2021 was $1.32M, a 16.9% decline from 2020.
  • Htg Molecular Diagnostics, Inc annual Share-based Payment Arrangement, Expense for 2020 was $1.58M, a 37% increase from 2019.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $643K $137K -$131K -48.8% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $774K $100K -$175K -63.5% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-30
Q3 2022 $949K $175K -$164K -48.4% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $1.11M $231K -$121K -34.4% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $1.23M $268K -$83.1K -23.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $1.32M $275K -$130K -32.1% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 $1.45M $339K -$53.3K -13.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $1.5M $352K -$14.4K -3.92% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 $1.52M $351K -$69.7K -16.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $1.58M $405K +$93.6K +30.1% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-29
Q3 2020 $1.49M $392K +$75.6K +23.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $1.42M $367K +$79.5K +27.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $1.34M $421K +$179K +74.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $1.16M $311K +$66.7K +27.3% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-25
Q3 2019 $1.09M $317K +$58.6K +22.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $1.03M $287K +$45.4K +18.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
Q1 2019 $986K $241K -$902K -78.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 $1.89M $245K -$19.4K -7.35% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-25
Q3 2018 $1.91M $258K -$99.4K -27.8% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $2.01M $242K -$176K -42.1% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $2.18M $1.14M +$747K +188% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $1.44M $264K -$186K -41.3% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-07
Q3 2017 $1.62M $357K +$127K +55.4% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $1.49M $418K +$266K +175% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $1.23M $397K +$227K +133% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $1M $450K +$268K +148% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-23
Q3 2016 $734K $230K +$153K +198% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $581K $152K +$82.1K +117% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 $499K $170K +$93.5K +122% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 $405K $182K Oct 1, 2015 Dec 31, 2015 10-K 2017-03-23
Q3 2015 $77.2K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 $70K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $76.5K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.